Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-γ, and tumor necrosis factor α in the early disease stage

Arthritis and Rheumatism

Volumn 40, Issue 3, 1997, Pages 540-550

  Gruschwitz, Matthias S ^a   Vieth, Gisela ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; T LYMPHOCYTE;

ADULT; AGED; CHRONIC DISEASE; CYTOLOGICAL TECHNIQUES; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0030936758     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400321     Document Type: Article

References (53)

1. Krieg T, Meurer M: Systemic scleroderma. J Am Acad Dermatol 18:457-481, 1988
2. Jayson MIV, Black CM: Systemic Sclerosis: Scleroderma. Chichester, UK, John Wiley and Sons, 1988
3. Fleischmajer R, Perlish JS, Reeves JRT: Cellular infiltrates in scleroderma skin. Arthritis Rheum 20:975-984, 1977
4. Kahaleh MB: Vascular disease in scleroderma: endothelial T lymphocyte-fibroblast interactions. Rheum Dis Clin North Am 16:53-73, 1990
5. Kähäri V-M, Sandberg M, Kalimo H, Vuorio T, Vuorio E: Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol 90:664-670, 1988
6. Scharffetter K, Lankat-Buttgereit B, Krieg T: Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest 18:9-17, 1988
7. Gruschwitz M, Müller PU, Sepp N, Hofer E, Fontana A, Wick G: Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 94:197-203, 1990
8. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T: Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 86:917-922, 1990
9. Gruschwitz MS: Expression of TNF-α, PDGF and bFGF in early scleroderma skin lesions, cultured skin fibroblasts and on PBMC (abstract). J Invest Dermatol 102:633A, 1994
10. Gruschwitz M, von den Driesch P, Kellner I, Hornstein OP, Sterry W: Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis. J Am Acad Dermatol 27:169-177, 1992
11. Steinman RM, Nussenzweig MC: Dendritic cells: features and functions. Immunol Rev 53:125-147, 1980
12. Suitters AJ, Lampert TA: Expression of la antigen on epidermal keratinocytes is a consequence of cellular immunity. Br J Exp Pathol 63:207-213, 1982
13. Umetsu DT, Katzen D, Jabara HH, Geha RS: Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes. J Immunol 136:440-445, 1986
14. Pober JS, Gimbrone MAJ, Collins T, Cotran RS, Ault KA, Fiers W, Krensky AM, Clayberger C, Reiss CS, Burakoff SJ: Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cell surface antigens. Immunobiology 168:483-494, 1984
15. Gallatin WM, Weissman IL, Butcher EC: A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30-34, 1983
16. Bottazzo GF, Pujol-Borrell A, Hanafusa T, Feldman M: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115-1119, 1983
17. Wick G, Moest J, Schauenstein K, Krömer G, Dietrich H, Ziemiecki A, Faessler R, Schwarz S, Neu N, Hala K: Spontaneous autoimmune thyroiditis - a birds-eye view. Immunol Today 6:359-364, 1985
18. Gruschwitz M, Sepp N, Kofler H, Wick G: Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis. Immunobiology 182:234-255, 1991
19. Branchet MC, Boisnic S, Blétry O, Robert L, Charron D, Francès C: Expression of HLA class II antigens on skin fibroblasts in scleroderma. Br J Dermatol 126:431-435, 1992
20. Griffiths CEM, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617-629, 1989
21. Groves RW, Ross E, Barker JNWN, MacDonald DM: Vascular cell adhesion molecule-1 (VCAM-1) expression in normal and diseased skin: regulation in vivo by interferon-gamma. J Am Acad Dermatol 29:67-72, 1993
22. Groves RW, Allen MH, Barker JNWN, Haskard DO, MacDonald DM: Endothelial leukocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 124:117-123, 1991
23. Gruschwitz MS, Hornstein OP, von den Driesch P: Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 38:184-189, 1995
24. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70:427-451, 1990
25. Groves RW, Allen MH, Ross EL, Barker JNWN, MacDonald DM: Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 132:345-352, 1995
26. Manyak CL, Tse H, Fischer P, Coker L, Sigal NH, Koo GC: Regulation of class II MHC molecules on human endothelial cells: effects of IFN and dexamethasone. J Immunol 140:3817-3821, 1988
27. Geppert TD, Lipsky PE: Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable la expression. J Immunol 135:3750-3762, 1985
28. Aichinger G, Fill H, Wick G: In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis. Lab Invest 52:132-140, 1985
29. Khoury EL, Price VH, Greenspan JS: HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol 90:193-200, 1988
30. "Arbeitsgruppe Sklerodermie" der Arbeitsgemeinschaft Dermatologische Forschung (ADF): Klinik der progressiven systemischen Skferodermie (PSS). Hautarzt 37:320-324, 1986
31. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
32. Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, LeRoy EC: A modified scleroderma skin scoring method. Clin Exp Rheumatol 4:969-972, 1986
33. Wick G, Baudner S, Herzog F: Immunofluorescence. Second English edition. Marburg/Lahn, Medizinische Verlagsgesellschaft, Germany, 1976
34. Cordell JL, Falini B, Erber WN, Ghosh AK, Addulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem 32:219-229, 1984
35. Schauenstein K, Wick G, Kink H: The micro-membrane-fluorescence test: a new semiautomated technique based on the microtiter system. J Immunol Methods 10:143-150, 1976
36. Rosenthal AS, Shevach EM: Function of macrophages in antigen recognition by guinea pig lymphocytes. I. Requirement for histo-compatible macrophages and lymphocytes. J Exp Med 138:1194-1212, 1973
37. Weinberger O, Herrman SH, Mescher MF, Benacerraf B, Burakoff SJ: Cellular interactions in the generation of cytotoxic T lymphocyte responses: role of la positive splenic adherent cells in presentation of H-2 antigen. Proc Natl Acad Sci U S A 77:6091-6095, 1980
38. Raff HV, Picker LJ, Stobo JP: Macrophage heterogeneity in man: a subpopulation of HLA-DR bearing macrophages required for antigen induced T cell activation also contains stimulators for autologous-reactive T cells. J Exp Med 152:581-593, 1980
39. Lechler RI: Structure-function relationships of MHC class II molecules. Immunology 1:25s-26s, 1988
40. Londei M, Lamb JR, Bottazzo GF, Feldmann M: Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639-641, 1984
41. Basham TY, Nickoloff BJ, Merigan TC, Morhenn VB: Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol 83:88-90, 1984
42. Herman B, Duncan MR, Smith B, Ziboh VA, Palladino M: Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells. J Invest Dermatol 84:54-58, 1985
43. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, Ault KA, Gimbrone MA, Strominger JL, Pober JS: Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci U S A 81:4917-4921, 1984
44. Xiao BG, Zhang GX, Ma CG, Link H: Transforming growth factor-beta 1 (TGF-βl)-mediated inhibition of glial cell proliferation and downregulation of intercellular adhesion molecule-1 (ICAM-1) are interrupted by interferon-gamma (IFN-gamma). Clin Exp Immunol 103:475-481, 1996
45. Panek RB, Lee YJ, Benveniste EN: TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression. J Immunol 154:610-619, 1995
46. Muller J, Yoshida T: Interaction of murine peritoneal leukocytes and mesothelial cells: in vitro model system to survey cellular events on serosal membranes during inflammation. Clin Immunol Immunopathol 75:231-238, 1995
47. Swerlick RA, Garcia-Gonzalez E, Kubota Y, Xu YL, Lawley TJ: Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol 97:190-196, 1991
48. Fabry Z, Waldschmidt MM, Hendrickson D, Keiner J, Love-Homan L, Takei F, Hart MN: Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55. J Neuroimmunol 36:1-11, 1992
49. Suzuki Y, Tanigaki T, Heimer D, Wang W, Ross WG, Murphy GA, Sakai A, Sussman HH, Vu TH, Raffin TA: TGF-beta 1 causes increased endothelial ICAM-1 expression and lung injury. J Appl Physiol 77:1281-1287, 1994
50. Hirschberg H, Bergh OJ, Thorsby E: Antigen-presenting properties of human vascular endothelial cells. J Exp Med 152:249S-255S, 1980
51. Wagner CR, Vetto RM, Burger DR: Subcultured human endothelial cells can function independently as fully competent antigen presenting cells. Hum Immunol 13:33-47, 1985
52. Umetsu DT, Pober JS, Jabara HA, Fiers W, Yunis EJ, Burakoff SJ, Reiss CS, Geha RS: Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. J Clin Invest 76:254-258, 1985
53. Iribe H, Koga T, Kotani S, Kusomoto S, Shiba T: Stimulating effect of MDP and its adjuvant-active analogues on guinea pig fibroblasts for the production of thymocyte-activating factor. J Exp Med 157:2190-2195, 1983